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Introduction 
 
COVID-19, a recently established global pandemic, is linked to infection by the SARS-
CoV-2 virus. This virus shares many structural similarities to the SARS-CoV virus that was 
responsible for the 2003-2004 SARS outbreak1.SARS-CoV-2 (thought to be a -coronavirus of 
B lineage2) is responsible for causing COVID-19 and shares many similarities to other viruses 
in the coronavirus family. Coronavirus comprise the Coronavirinae subfamily, which exists 
within the Coronaviridae family of the Nidovirales order3. Coronavirinae make up the largest 
of viruses, being approximately 30 kilobases long, and contain positive-sense RNA strands 
enveloped in a nucleocapsid (unusual for positive-sense RNA)4. The spike protein (S) 
participates in the binding of the angiotensin-converting enzyme 2 (ACE2) and subsequent 
fusion of the viral and host cellular membrane. It is comprised of 22 of the 23 N-glycosylation 
sites that are found in SARS-CoV, and 76% of the protein’s genomic sequence is shared 
between the two viruses2,5. This review discusses the mechanism of action between the S 
protein and the host cell receptor. 
 
1. Overview of Spike Protein Function 
 
 The general process of SARS-CoV-2 entry into host cells is well known. It is the result 
of a multi-step process that involves structural changes and processing of the spike protein6. 
The spike protein (S) is a homo-trimer7, with each monomer composed of S1 and S2 subunits. 
Following S cleavage by the host proteases, such as furin or trypsin, S1 and S2 are connected 
via non-covalent bonds. This bound, prefusion conformation of the subunits exhibit the ideal 
arrangement for subsequent cleavage of the S2 subunit that allows for the fusion of viral 
membrane with that of the host cell.  
 
The S2 subunit is further cleaved by host proteases at a site known as S2’ to facilitate 
fusion with the host cell8. Hoffmann et al. demonstrate the importance of the serine protease 
TMPRSS2 in preparing the S protein for fusion5. This allows for a hydrophobic internal fusion 
peptide to be inserted into the transmembrane, forming an intermediate pre-hairpin 
structure with the host cell9. The presence of this fusion peptide, along with two heptad-
repeat regions (HR1 and HR2), have led researchers to classify the S glycoprotein as a class I 
fusion protein. Key differences between the S protein and other class I fusion proteins, 
however, may warrant a reevaluation of this categorization10. Incidentally, the similarities in 
HR1 and HR2 sequence alignment between that of HIV and SARS-CoV9 (and SARS-CoV-2, by 
extension) may also provide clearer insight into the high infection rate seen with COVID-19. 
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 S1 SUBUNIT S2 SUBUNIT 
PRIMARY FUNCTION Receptor binding Membrane fusion 
LOCATION IN SPIKE GENE 
SEQUENCE 
N-terminus to linker region Linker region to C-terminus 
CLEAVAGE SITE S1/S2 (between CTD and 
linker region) 
S2’ (between linker region 
and fusion peptide) 
CONTAINS N-terminal domain (NTD) 
and C-terminal domain 
(CTD) 
Fusion peptide, heptad 
repeats 1 and 2 (HR1, HR2), 
transmembrane domain 
(TM) and ectodomain (E) 
 
Table 1. Comparison of the S1 and S2 subunits of the SARS-CoV-2 spike protein 
  
2. Amino Acid Residue Interactions 
 
 In humans, the spike protein of SARS-CoV-2 is observed to bind with high affinity to 
ACE2. In a 2020 study on recognition between the two, Yan et al.8 attempt to rationalize the 
strong binding pattern through a study of the peptidase domain (PD) of ACE2 bound to the 
RBD of the S protein. Their research suggests that changes in the positioning of nonpolar 
residues in SARS-CoV-2 may account for the formation of salt bridges and van der Waals 
interactions, leading to stronger associations between the RBD and peptidase domain (PD) in 
ACE2 in some areas, and weaker interactions in others. 
  
Chen et al. propose that a difference in a single amino acid residue (F486) in the RBD 
sequence of SARS-CoV and SARS-CoV-2 corresponds to increased binding to ACE2 because 
phenylalanine, having a large, nonpolar R-group, is able to better insert into the ACE2 binding 
pocket2. Other research, on the other hand, presents evidence of drastically enhanced 
binding between the RBD in SARS-CoV-2 and ACE2 due to a mutation from Arg to Thr at the 
501 position1. Additionally, other variations in the RBD between the two -coronaviruses may 
have a direct impact on binding affinity8.  
 
3. Receptor Recognition by Spike Proteins 
 
 Host cell recognition by SARS-CoV-2 is the first step in COVID-19 infection7. Receptor 
binding in SARS-CoV has been shown to be triggered indirectly by low pH in the surrounding 
environment, which induces the lysosomal release of proteases that cleave the S1 and S2 
subunits6. There is a strong possibility that these findings may be similar to the triggering of 
SARS-CoV-2 binding. The specific role that ACE2 plays in viral infection remains unclear. There 
is recent evidence to support that ACE2 is cleaved near the C-terminus by host proteases as 
well, further facilitating SARS-CoV-2 entry into exposed cells8. There is debate, however, on 
whether cleavage at S2’ is essential for membrane fusion10,11. Inhibition of this process could 
prove a potent target for COVID-19 treatments.  
  
Much of the recent research on human CoV-2 infections have focused on establishing the 
similarities and differences between the S protein mechanism of action in SARS-CoV and 
SARS-CoV-2. The interaction between the receptor binding domain (RBD) of the virus and host 
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receptor is a key step in the infection of an organism. The RBD is found in the S1 subunit, on 
the outermost point of the S protein3. Peptidases, such as ACE2, are typically used as 
receptors, although binding has been observed in instances absent these enzymes. Previous 
studies have presented observations of binding between S1 in -coronaviruses and sugar-
mediated receptors12. As an attempt to understand SARS-CoV-2 binding in the absence of 
ACE2, Ibrahim et al.7 studied how the spike protein on the novel coronavirus binds to glucose 
regulating protein 78 (GRP78). Molecular docking revealed hydrogen bonding and van der 
Waals interactions between S1 and GRP78, resulting in efficient binding to a non-protease 
receptor. Successful binding between SARS-CoV-2 and a sugar receptor may be linked to non-
respiratory-related symptoms attributed to COVID-19.  
 
4. Fusion of S Protein with Host Cell Membrane 
 
 There are two mechanisms by which membrane fusion occurs: syncytia formation and 
endocytosis. Research indicates that the pathway by which SARS-CoV-2 can enter a host cell 
depends upon the presence of certain proteases, although there is some speculation that the 
type of receptor determines which fusion mechanism is used11. However, endocytosis is 
observed in most CoV-2 infections in human cells6,11. Shulla et al.13 propose that palmitic acid 
tails on the S protein are responsible for meditating endocytic entry into host cells. By 
comparing the fusion ability of wild-type S proteins to Cys→ Ala residues in the TM-E region 
of the S2 subunit, the importance of this fatty acid chain in viral infection was highlighted. 
  
Preliminary research into the thermodynamics of SARS-CoV-2 fusion activation reveals 
heightened luciferase activity at physiological temperatures compared to SARS-CoV11. As 
luciferases embody a broad class of oxidative enzymes, more attention should be focused on 
determining the specific metabolic pathways that are affected by CoV-2 infection. Bosch et 
al. also studied the function of the fusion subunit in high thermal conditions10. HR1 and HR2 
were found to be stable at temperature up to 70C, high above temperatures that the human 
body can withstand. This demonstrates the persistence of the virus activity despite drastic 
changes in environment.  
   
 Conclusions 
 
Preventing ACE2 dimerization may be associated with decreased binding affinity. The Kd 
of SARS-CoV-2 has been determined to be approximately 15 nM8, so an effective receptor-
recognition targeting treatment should have a lower dissociation constant. Further 
investigation into the gene sequence of SARS-CoV-2 may also provide better insight into its 
more efficient binding to ACE2, compared to other -coronaviruses. Additionally, an 
exploration of the prevalence of viral infection in cases where ACE2 concentration is low or 
nonexistent will prove useful in understanding the specific role that protease receptors play 
in binding and fusion. Lastly, an in-depth study of the interactions between the 
transmembrane proteins should be conducted to fully grasp the mechanics of SARS-CoV-2 
fusion.  
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 There is a substantial amount of research to suggest that SARS-CoV-2 uses the same 
mode of entry into host cells through the same receptor as the virus responsible for the SARS 
outbreak in 2003-2004. Although the mechanism of action of the SARS-CoV-2 virus has been 
the focus of many studies as of late, further exploration into possibilities for blocking the 
binding of the virus to human ACE2 is necessary. Specifically, the non-covalent interactions 
between the gene sequence of ACE2 and that of SARS-CoV-2 requires better understanding 
in order to design effective treatments and vaccines. 
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